Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors

Bone Marrow Transplantation

Volumn 18, Issue 5, 1996, Pages 885-890

  Korbling M ^a,b   Chan, K W ^a   Anderlini, P ^a   Seong, D ^a   Durett, A ^a   Langlinais, A ^a   Przepiorka, D ^a   Gajewski, J ^a   Miller, P ^a   Sundberg, J ^a   Alilaen, P ^a   Bojko, P ^a   Mirza, N ^a   Claxton, D ^a   Van Besien, K ^a   Khouri, I ^a   Andersson, B ^a   Mehra, R ^a   Champlin, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Allogeneic blood stem cell transplantation; Apheresis; Normal pediatric blood stem cell donors; rhG CSF stem cell mobilization

Indexed keywords

ANTICOAGULANT AGENT; CD34 ANTIGEN; HEPARIN; HUMAN SERUM ALBUMIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; APHERESIS; ARTICLE; BLOOD VOLUME; CANCER REGRESSION; CLINICAL ARTICLE; DONOR; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC SYNDROME; HLA MATCHING; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; STEM CELL TRANSPLANTATION; VASCULAR ACCESS;

ADULT; AGE FACTORS; BLOOD CELL COUNT; BLOOD COMPONENT REMOVAL; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; RECOMBINANT PROTEINS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 10544226870     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
2. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
3. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
4. Przepiorka D, Anderlini P, Ippoliti C et al. Allogeneic blood stem cell transplantation: reduction in early treatment-related morbidity and mortality for patients with advanced hematologic malignancies. Bone Marrow Transplant (in press).
5. Anderlini P, Przepiorka D, Seong D et al. Clinical toxicity, laboratory effects and analysis of charges for filgrastim mobilization and blood stem cell apheresis from normal donors. Transfusion (in press).
6. Chan KW, Gajewski JL, Supkis D et al. The use of minors as bone marrow donors: current attitude and management. A survey of 56 pediatric transplant centers. J Pediatrics 1996; 128: 644-648.
7. Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
8. dim) and lymphoid subsets, and possible predictors of engraftment and GVHD. Blood 1995; 86: 2842-2848.
9. Kanold J, Rapatel C, Berger M et al. Use of G-CSF alone to mobilize peripheral blood stem cells for collection from children. Br J Haematol 1994; 88: 633-635.
10. Takaue Y, Kawano Y, Abe T et al. Collection and transplantation of peripheral blood stem cells in very small children weighing 20 kg or less. Blood 1995; 86: 372-380.